Sigyn Therapeutics Inc
(SIGY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,340 | -4,146 | -2,930 | -3,005 | -1,260 |
| Depreciation Amortization | 469 | 1,765 | 657 | 387 | 287 |
| Accounts payable and accrued liabilities | 147 | 197 | 317 | 24 | 15 |
| Other Working Capital | 1,264 | 850 | 307 | -34 | 75 |
| Other Operating Activity | 587 | -49 | -181 | 853 | 53 |
| Operating Cash Flow | $-872 | $-1,383 | $-1,830 | $-1,774 | $-830 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -1 | -29 | -11 |
| Investing Cash Flow | $N/A | $N/A | $-1 | $-29 | $-11 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 953 | 1,312 | 1,567 | 250 | 925 |
| Common Stock Issued | N/A | N/A | N/A | 1,865 | N/A |
| Other Financing Activity | -80 | 75 | -69 | -55 | 0 |
| Financing Cash Flow | $873 | $1,387 | $1,499 | $2,060 | $925 |
| Beginning Cash Position | 12 | 8 | 341 | 84 | N/A |
| End Cash Position | 12 | 12 | 8 | 341 | 84 |
| Net Cash Flow | $1 | $3 | $-333 | $257 | $84 |
| Free Cash Flow | |||||
| Operating Cash Flow | -872 | -1,383 | -1,830 | -1,774 | -830 |
| Capital Expenditure | N/A | N/A | -1 | -29 | -11 |
| Free Cash Flow | -872 | -1,383 | -1,831 | -1,804 | -841 |